无创产前检测时代详细早孕期超声的价值
该回顾性队列研究纳入2020年1月1日至2022年12月31日单中心2158例孕妇的2216个胎儿,均接受无创产前检测(NIPT)和11.0–13.6周详细早孕期超声。在NIPT低危胎儿中,5.4%(116/2151)早孕期超声至少1项异常,提示早孕期超声与NIPT联合应用可发现更多需随访的胎儿。
要点
- NIPT低危胎儿中5.4%(116/2151)早孕期超声至少1项异常。
- NIPT低危组最常见筛查指标异常为鼻骨缺失(52/2151,2.4%)。
- NIPT低危组最常见结构缺陷为心脏异常(15/2151,0.7%)。
核心结论
- 详细早孕期超声发现的潜在异常胎儿多于单用NIPT,早孕期超声仍是应与NIPT联合使用的有价值筛查方法。
研究设计与样本
- 回顾性队列研究,纳入2020年1月1日至2022年12月31日单中心2158例孕妇的2216个胎儿,均接受NIPT和11.0–13.6周详细早孕期超声,采用描述性统计。
主要发现
- 2216个胎儿中,NIPT高危65个(3.0%),NIPT低危2151个(97.0%)。
- NIPT低危胎儿中,早孕期超声正常2035个(94.6%),至少1项异常116个(5.4%)。
- NIPT低危组最常见筛查指标异常为鼻骨缺失(52/2151,2.4%),其次为静脉导管a波反向(30/2151,1.4%)。
- NIPT低危组最常见结构缺陷为心脏异常(15/2151,0.7%)。
- 通过NIPT高危(n=65)或NIPT低危但早孕期超声异常(n=116)共识别181个胎儿为「筛查异常」。
关键数值与推荐
- NIPT结果分为低危或高危,早孕期超声结果分为正常或异常。
- 早孕期超声异常进一步分为早孕期筛查指标(颈项透明层增厚、鼻骨缺失、三尖瓣反流、静脉导管a波反向)或结构缺陷(颅骨、颈、心脏、胸廓、腹壁、胃、肾、膀胱、脊柱和四肢)。
临床怎么用
- 与单用NIPT相比,联合早孕期超声筛查额外识别116个胎儿(5.4%)需进一步随访和监测。
- 作者结论认为详细早孕期超声应与NIPT联合使用。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: In 2020, the American College of Obstetricians and Gynecologists recommended noninvasive prenatal testing be offered to all patients. However, current societal guidelines in the United States do not universally recommend a detailed first-trimester ultrasound. OBJECTIVE: This study aimed to determine the additional findings identified through first-trimester ultrasound that would have otherwise been missed if noninvasive prenatal testing was used alone as a first-trimester screening method. STUDY DESIGN: This was a retrospective cohort study involving 2158 pregnant patients and 2216 fetuses that were seen at a single medical center between January 1, 2020, and December 31, 2022. All those included underwent both noninvasive prenatal testing and detailed first-trimester ultrasound between 11.0 and 13.6 weeks of gestation. Noninvasive prenatal testing results were categorized as low risk or high risk, and first-trimester ultrasound results were categorized as normal or abnormal. Abnormal first-trimester ultrasounds were further classified as first-trimester screening markers (increased nuchal translucency, absent nasal bone, tricuspid regurgitation, and ductus venosus reverse a-wave) or structural defects (the cranium, neck, heart, thorax, abdominal wall, stomach, kidneys, bladder, spine, and extremities). Descriptive statistics were used to report our findings. RESULTS: Of 2216 fetuses, 65 (3.0%) had a high-risk noninvasive prenatal testing result, whereas 2151 (97.0%) had a low-risk noninvasive prenatal testing result. Of those with a low-risk noninvasive prenatal testing result, 2035 (94.6%) had a normal first-trimester ultrasound, whereas 116 (5.4%) had at least 1 abnormal finding on first-trimester ultrasound. The most common screening marker detected within the low-risk noninvasive prenatal testing group was absent nasal bone (52/2151 [2.4%]), followed by reversed a-wave of the ductus venosus (30/2151 [1.4%]). The most common structural defect in this group was cardiac abnormality (15/2151 [0.7%]). Overall, 181 fetuses were identified as having "abnormal screening" through either a high-risk noninvasive prenatal testing result (n=65) or through a low-risk noninvasive prenatal testing result but abnormal first-trimester ultrasound (n=116). In summary, the incorporation of first-trimester ultrasound screening identified 116 additional fetuses (5.4%) that required further follow-up and surveillance than noninvasive prenatal testing alone would have identified. CONCLUSION: Detailed first-trimester ultrasound identified more fetuses with a potential abnormality than noninvasive prenatal testing alone. Therefore, first-trimester ultrasound remains a valuable screening method that should be used in combination with noninvasive prenatal testing.
引用
- Esteves KM, Tugarinov N, Lechmann G, et al. The value of detailed first-trimester ultrasound in the era of noninvasive prenatal testing. Am J Obstet Gynecol. 2023. PMID: 37271433. doi:10.1016/j.ajog.2023.05.031
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。